United Services Automobile Association decreased its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 0.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 619,277 shares of the medical research company’s stock after selling 2,499 shares during the period. United Services Automobile Association owned approximately 0.16% of Thermo Fisher Scientific worth $95,121,000 as of its most recent filing with the SEC.
Other large investors also recently modified their holdings of the company. C WorldWide Group Holding A S boosted its stake in shares of Thermo Fisher Scientific by 997.1% in the first quarter. C WorldWide Group Holding A S now owns 1,950,049 shares of the medical research company’s stock worth $299,527,000 after buying an additional 1,772,300 shares during the period. NN Investment Partners Holdings N.V. boosted its stake in Thermo Fisher Scientific by 458.2% in the first quarter. NN Investment Partners Holdings N.V. now owns 528,598 shares of the medical research company’s stock worth $81,194,000 after buying an additional 433,898 shares during the period. Findlay Park Partners LLP boosted its stake in Thermo Fisher Scientific by 20.8% in the first quarter. Findlay Park Partners LLP now owns 2,032,151 shares of the medical research company’s stock worth $312,138,000 after buying an additional 350,000 shares during the period. Swiss National Bank boosted its stake in Thermo Fisher Scientific by 27.5% in the first quarter. Swiss National Bank now owns 1,399,732 shares of the medical research company’s stock worth $214,999,000 after buying an additional 301,600 shares during the period. Finally, Karp Capital Management Corp acquired a new stake in Thermo Fisher Scientific during the first quarter worth approximately $46,008,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Thermo Fisher Scientific Inc (NYSE:TMO) traded up 0.15% during mid-day trading on Friday, reaching $176.01. The company had a trading volume of 395,813 shares. The company has a market capitalization of $68.64 billion, a price-to-earnings ratio of 30.66 and a beta of 1.06. The firm’s 50 day moving average price is $176.88 and its 200-day moving average price is $164.14. Thermo Fisher Scientific Inc has a 12 month low of $139.07 and a 12 month high of $182.87.
Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.03. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The firm’s revenue was up 10.2% compared to the same quarter last year. During the same period in the prior year, the business earned $2.03 EPS. Equities research analysts anticipate that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.34%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s payout ratio is 10.45%.
WARNING: “United Services Automobile Association Sells 2,499 Shares of Thermo Fisher Scientific Inc (NYSE:TMO)” was reported by Stock Observer and is the sole property of of Stock Observer. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://www.thestockobserver.com/2017/08/04/united-services-automobile-association-lowers-position-in-thermo-fisher-scientific-inc-nysetmo-updated.html.
TMO has been the subject of a number of research analyst reports. Cantor Fitzgerald initiated coverage on Thermo Fisher Scientific in a research note on Thursday, May 18th. They issued an “overweight” rating and a $194.00 price target for the company. Barclays PLC set a $175.00 price target on Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Wednesday, April 26th. Cowen and Company reiterated an “outperform” rating and issued a $185.00 price target (up from $175.00) on shares of Thermo Fisher Scientific in a research note on Saturday, April 29th. Citigroup Inc. reiterated a “buy” rating and issued a $201.00 price target (up from $182.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 10th. Finally, BidaskClub upgraded Thermo Fisher Scientific from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 11th. One investment analyst has rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $188.56.
In other Thermo Fisher Scientific news, CFO Stephen Williamson sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $176.26, for a total transaction of $440,650.00. Following the transaction, the chief financial officer now owns 37,790 shares in the company, valued at approximately $6,660,865.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Daniel P. Shine sold 4,688 shares of the business’s stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $171.88, for a total value of $805,773.44. Following the transaction, the insider now owns 29,200 shares in the company, valued at approximately $5,018,896. The disclosure for this sale can be found here. Insiders have sold a total of 27,188 shares of company stock worth $4,702,223 in the last quarter. 0.49% of the stock is currently owned by insiders.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com’s FREE daily email newsletter.